Sitagliptin Decreases Visceral Fat and Blood Glucose in PCOS Sitagliptin Decreases Visceral Fat and Blood Glucose in PCOS

What benefits might the DPP-4 inhibitor sitagliptin offer to women with PCOS?Journal of Clinical Endocrinology & Metabolism

Source: Medscape Radiology Headlines - January 31, 2020 Category: Radiology Tags: Diabetes & Endocrinology Journal Article Source Type: news